Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 7 peer-reviewed journal articles Updated
Genetics

The SLC26A2 Spectrum: Where DTD Fits In

At a Glance

Diastrophic Dysplasia (DTD) is an intermediate condition on the SLC26A2 gene spectrum. This gene controls sulfate flow to cartilage. DTD causes a low flow of sulfate, leading to orthopedic challenges without the fatal complications seen in more severe forms.

If you have been researching Diastrophic Dysplasia (DTD) online, you may have come across several different names for conditions that seem similar but have very different outcomes. It can be confusing to see terms like Achondrogenesis Type 1B or rMED and wonder how they relate to your child.

The answer lies in the SLC26A2 gene. This single gene is responsible for a “family” of related conditions known as the SLC26A2-related skeletal dysplasias [1].

The “Sulfate Tap” Analogy

Think of the SLC26A2 gene as a faucet that controls the flow of sulfate into your child’s cartilage cells [2]. Sulfate is the “fuel” needed to build strong, healthy cartilage. The specific combination of mutations your child has determines how much that “faucet” is turned on [1].

Doctors refer to this as a genotype-phenotype correlation—the specific genetic code (genotype) determines the physical characteristics and severity of the condition (phenotype) [1][3].

The Spectrum of Severity

The SLC26A2 spectrum is a continuum, and DTD sits right in the middle [1].

Condition Name Severity Residual Sulfate Transport (The “Faucet”)
Achondrogenesis Type 1B (ACG1B) Most Severe The faucet is completely closed. No sulfate enters the cells, which is why this form is typically lethal before or shortly after birth [1][4].
Atelosteogenesis Type 2 (AO2) Severe The faucet is just barely dripping. This form is also very severe and often life-threatening in the newborn period [1].
Diastrophic Dysplasia (DTD) Intermediate The faucet is on a “low flow” setting. Enough sulfate gets through to support life and growth, but not enough to build “standard” cartilage, leading to the characteristic features of DTD [1][5].
recessive Multiple Epiphyseal Dysplasia (rMED) Mildest The faucet is partially open. This is the mildest form, often appearing as joint pain or slightly short stature, sometimes not diagnosed until later in childhood [1][6].

Understanding Your Child’s Place

It is important to remember that although your child shares a gene mutation with children who have the more severe (lethal) or milder (rMED) forms, their path is determined by their specific combination of mutations [1].

  • Compound Heterozygosity: Most children with DTD are “compound heterozygotes,” meaning they inherited two different mutations in the SLC26A2 gene (one from each parent) [1][7]. One mutation might be a “severe” one, but the other might be a “milder” one that allows just enough sulfate transport for the child to thrive [1].
  • A Unique Path: While DTD is generally not a life-limiting condition in the long term, the neonatal period can present critical, life-threatening challenges such as severe airway or spinal issues [1]. While your child will face orthopedic challenges because of the “low flow” of sulfate, they are not expected to have the fatal complications seen at the most severe end of the spectrum.

When you see other conditions mentioned in the SLC26A2 family, you can think of them as distant cousins—related by the same gene “malfunction,” but each with its own very different clinical journey [2]. Your child’s medical team will focus specifically on the Diastrophic Dysplasia presentation, which has its own well-established management protocols [5].

Common questions in this guide

What is the SLC26A2 gene spectrum?
The SLC26A2 gene spectrum is a family of skeletal conditions caused by mutations in the same gene. It ranges from very mild conditions like rMED to severe, life-threatening conditions like Achondrogenesis Type 1B.
Where does Diastrophic Dysplasia (DTD) fall on the SLC26A2 spectrum?
DTD sits in the middle of the severity spectrum. It causes a 'low flow' of sulfate to cartilage cells, meaning children will face orthopedic challenges but generally avoid the fatal complications seen in the most severe forms.
What does compound heterozygosity mean for my child with DTD?
It means your child inherited two different mutations in the SLC26A2 gene, one from each parent. The unique combination of these two mutations helps determine the severity and physical characteristics of their specific condition.
How do SLC26A2 gene mutations affect my child's cartilage?
The SLC26A2 gene acts like a faucet that controls how much sulfate enters cartilage cells, which is the fuel needed to build strong cartilage. Mutations restrict this flow, preventing the body from building standard, healthy cartilage.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What specific mutations were found in my child's SLC26A2 gene?
  2. 2.Where do these specific mutations fall on the spectrum of sulfate transporter function?
  3. 3.How does my child's genotype help us predict their long-term growth and mobility?
  4. 4.Does my child's mutation combination suggest they have 'classic' DTD or a slightly milder or more severe version?
  5. 5.If we have more children, what is the likelihood they would be on a different part of this spectrum?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (7)
  1. 1

    SLC26A2/DTDST Spectrum: A Cohort of 12 Patients Associated with a Comprehensive Review of the Genotype-Phenotype Correlation.

    Silveira C, da Costa Silveira K, Lacarrubba-Flores MD, et al.

    Molecular syndromology 2023; (13(6)):485-495 doi:10.1159/000525020.

    PMID: 36660027
  2. 2

    Suppressing UPR-dependent overactivation of FGFR3 signaling ameliorates SLC26A2-deficient chondrodysplasias.

    Zheng C, Lin X, Xu X, et al.

    EBioMedicine 2019; (40()):695-709 doi:10.1016/j.ebiom.2019.01.010.

    PMID: 30685387
  3. 3

    Molecular characterization of central cytoplasmic loop in Aspergillus nidulans AstA transporter.

    Pilsyk S, Sieńko M, Perlińska-Lenart U, et al.

    Acta biochimica Polonica 2018; (65(4)):545-554 doi:10.18388/abp.2018_2620.

    PMID: 30427324
  4. 4

    Two unrelated pedigrees with achondrogenesis type 1b carrying a Japan-specific pathogenic variant in SLC26A2.

    Sato T, Kojima T, Samura O, et al.

    American journal of medical genetics. Part A 2020; (182(4)):735-739 doi:10.1002/ajmg.a.61469.

    PMID: 31880411
  5. 5

    SLC26A2-Associated Diastrophic Dysplasia and rMED-Clinical Features in Affected Finnish Children and Review of the Literature.

    Härkönen H, Loid P, Mäkitie O

    Genes 2021; (12(5)) doi:10.3390/genes12050714.

    PMID: 34064542
  6. 6

    Clinical and Genetic Characteristics of Multiple Epiphyseal Dysplasia Type 4.

    Markova T, Kenis V, Melchenko E, et al.

    Genes 2022; (13(9)) doi:10.3390/genes13091512.

    PMID: 36140680
  7. 7

    Genetic Association and Role of Surgery for the Treatment of Lower Limb Deformities in Diastrophic Dysplasia: A Case Report.

    Tripathi AK, Choudhary S, Singh V, Verma PK

    Journal of orthopaedic case reports 2021; (11(2)):81-85 doi:10.13107/jocr.2021.v11.i02.2036.

    PMID: 34141677

This page explains the SLC26A2 gene spectrum for educational purposes only and does not replace professional medical advice. Always consult a medical geneticist or pediatric specialist to interpret your child's specific genetic testing results.

Get notified when new evidence is published on Diastrophic dysplasia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.